MK-8748 (EYE201)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-8748 (EYE201), covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) [Phase 2, Phase 3]